Natalie K. Gilmore

MedicineBiochemistry, Genetics and Molecular BiologyEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans”.

Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans

Cell Reports Medicine(2026)10.1016/j.xcrm.2026.102665

N/A

0.330DataRank · unranked

8 citations

Natalie K. Gilmore, Christopher M.T. Hayden, Julien Roux, Bruno Bariohay, Thaïs Rouquet +17 more

Pharmacological weight loss with incretin-based therapies does not result in a disproportionate loss of muscle mass or function in obese mice and humans

medRxiv(2025)10.1101/2025.07.28.25332295

N/A

0DataRank · unranked

0 citations

Natalie K. Gilmore, C. E. Hayden, Julien Roux, Bruno Bariohay, Thaïs Rhouquet +15 more